Issue 17, 2020

Nanoformulations of core–shell type hydroxyapatite-coated gum acacia with enhanced bioactivity and controlled drug delivery for biomedical applications

Abstract

In this work, nanospherical hydroxyapatite (HAP) was prepared that has combined properties of controlled drug delivery, biocompatibility, and antibacterial activity to have applications in the biomedical sector. The composite was formed by the sintering of HAP in the presence of Gum acacia (GA) as an emulsifier (at 600 °C) and the composite's physical properties like nucleation, size, shape, crystallinity, and surface area were characterized using spectroscopic, electron microscopic and BET (Brunauer, Emmett and Teller) studies. Typical results of the FTIR study revealed the presence of characteristic phosphate and carbonate groups of HAP and XRD provided the mean crystallite size of GA-HAP in the range of 20–50 nm. The electron micrograph of GA-HAP showed nanorods with a smooth surface interspersed in GA with particle size <50 nm and a change of shape to spheres upon increasing the concentration of GA. The presence of C, O, Ca, and P confirmed through XPS was attributed to the major elemental composition of GA-HAP. Besides, BET studies indicated that the % of GA incorporated seemed to be greatly influenced by the porosity and surface area and this particular property determined the drug loading and leaching efficacy from the GA-HAP matrices when used for drug delivery applications. After bioactivity and leaching studies in the presence of SBF (simulated body fluid), we found that the increased concentration of GA (from 1% to 10%) caused a slowdown and sustained release/burst of the naringenin drug (43% over a 72 h period). Further, antibacterial studies using the clinical strains of bacteria proved that GA-HAP/N (drug-loaded GA-HAP) possessed excellent activity toward S. aureus and E. coli with inhibition zones of 26 mm and 32 mm, respectively. Besides, the biocompatibility and cytotoxicity of GA-HAP/N showed about 90% viability for McCoy cells with no sign of detachment after 72 h of treatment, while Saos-2 cells showed typical inhibition in growth associated with rounding off and detachment, signifying cytotoxicity. This selective toxicity induced by the drug-loaded GA-HAP might find application in drug delivery for precision medicine.

Graphical abstract: Nanoformulations of core–shell type hydroxyapatite-coated gum acacia with enhanced bioactivity and controlled drug delivery for biomedical applications

Article information

Article type
Paper
Submitted
08 Feb 2020
Accepted
30 Mar 2020
First published
23 Apr 2020

New J. Chem., 2020,44, 7175-7185

Nanoformulations of core–shell type hydroxyapatite-coated gum acacia with enhanced bioactivity and controlled drug delivery for biomedical applications

V. P. Padmanabhan, S. Balakrishnan, R. Kulandaivelu, S. N. T. S. N., M. Lakshmipathy, S. Sagadevan, F. Mohammad, H. A. Al-Lohedan, S. Paiman and W. C. Oh, New J. Chem., 2020, 44, 7175 DOI: 10.1039/D0NJ00668H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements